Difficulties in management of a sighted patient with non-24-hour sleep-wake rhythm disorder
DOI:
https://doi.org/10.34119/bjhrv7n9-221Keywords:
non-24-hour sleep-wake rhythm disorder (N24HSWRD), sleep disorders, actigraphyAbstract
The non-24-hour sleep-wake rhythm disorder (N24HSWRD) is a rare circadian condition, often observed in totally blind individuals but uncommon in those with normal vision. This case report describes a 16-year-old male patient who has exhibited alterations in his sleep rhythm since birth, characterized by progressive sleep delays and a reversal of the sleep-wake cycle. The diagnosis was challenging, involving multiple medical consultations and the necessity for unsuccessful sleep hygiene interventions. Initial treatment with melatonin showed satisfactory results, but the patient developed tolerance over time, particularly during adolescence, when the delay in the cycle increased to three hours per day. Actigraphy confirmed the diagnosis and highlighted the importance of this method in the evaluation of sleep disorders. Although treatment with melatonin and phototherapy is recommended, the lack of standardization and treatment adherence complicate the management of N24HSWRD. This case underscores the complexity of diagnosing and treating circadian sleep disorders, emphasizing the need for increased awareness and adequate diagnostic resources outside major medical centers.
References
Czeisler CA, Shanahan TL, Klerman EB, Martens H, Daniel J. Brotman DJ, Emens JS, et al. Suppression of Melatonin Secretion in Some Blind Patients by Exposure to Bright Light. N Engl J Med. 1995; 332:6-11.
Endara-Bravo AS, Thammasitboon S, Thomas D. Free-running disorder in a sighted adolescent. The Journal of pediatrics. 2012;160(5):877.
Ferri L, Filardi M, Moresco M, Pizza F, Vandi S, Antelmi E, et al. Non-24-Hour Sleep-Wake Rhythm Disorder and Melatonin Secretion Impairment in a Patient With Pineal Cyst. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2017;13(11):1355-7.
Garbazza C, Bromundt V, Eckert A, Brunner DP, Meier F, Hackethal S, et al. Non-24-Hour Sleep-Wake Disorder Revisited - A Case Study. Frontiers in neurology. 2016;7:17.
Hayakawa T, Uchiyama M, Kamei Y, Shibui K, Tagaya H, Asada T, et al. Clinical analyses of sighted patients with non-24-hour sleep-wake syndrome: a study of 57 consecutively diagnosed cases. Sleep. 2005;28(8):945-52.
Hirose M, Arakawa C, Watanabe A, Esaki Y, Kawai R, Iwata N. Treatment outcome of non-24-hour sleep–wake rhythm disorder: a retrospective study of 24 consecutive cases in a sleep clinic. Fujita Medical Journal. 2018;4(3):70-6.
Lee D, Shin WC. Forced entrainment by using light therapy, modafinil and melatonin in a sighted patient with non-24-hour sleep-wake disorder. Sleep medicine. 2015;16(2):305-7.
Lockley SW, Dressman MA, Licamele L, Xiao C, Fisher DM, Flynn-Evans EE, et al. Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials. Lancet. 2015;386(10005):1754-64.11.
Malkani RG, Abbott SM, Reid KJ, Zee PC. Diagnostic and Treatment Challenges of Sighted Non-24-Hour Sleep-Wake Disorder. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2018;14(4):603-13.
Okawa M, Uchiyama M. Circadian rhythm sleep disorders: characteristics and entrainment pathology in delayed sleep phase and non-24-h sleep-wake syndrome. Sleep medicine reviews. 2007;11(6):485-96.
Quante M, Kaplan ER, Cailler M, Rueschman M, Wang R, Weng J, et al. Actigraphy-based sleep estimation in adolescents and adults: a comparison with polysomnography using two scoring algorithms. Nat Sci Sleep. 2018; 10:13–20.
Russell C, Wearden AJ, Fairclough G, Emsley RA, Kyle SD; Subjective but Not Actigraphy-Defined Sleep Predicts Next-Day Fatigue in Chronic Fatigue Syndrome: A Prospective Daily Diary Study. Sleep 2016;39(4):937–944.
Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387-94.
Yanagihara M, Nakamura M, Usui A, Nishida S, Ito E, Okawa M, et al. The melatonin receptor agonist is effective for free-running type circadian rhythm sleep disorder: case report on two sighted patients. The Tohoku journal of experimental medicine. 2014;234(2):123-8.
